Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults
Clinical trial NCT05188677 · COMPLETED
Trial details
- NCT number
- NCT05188677
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2023-06-06
- Enrollment
- 1831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.